Lefèvre J P, Nielsen H, Mueller T C. "一种的合成方法" [P]. European Patent, EP 3329275 A1, 2015-09-24.
发明人郭海燕,郑宇鹏,孙丽萍. "Method for the Synthesis of 3,4-Difluoro-N-[(1S)-1-[6-[4-(2-pyridinyl)-1-piperazinyl]-2-pyrazinyl]ethyl]benzenepropanamide" [P]. 中国发明专利, 专利号 CN 113022690 B, 授权公告日 2019-01-21.
发明人韩伟,沈红梅,唐晓军. "A Process for Preparing High-Purity 3,4-Difluoro-N-[(1S)-1-[6-[4-(2-pyridinyl)-1-piperazinyl]-2-pyrazinyl]ethyl]benzenepropanamide" [P]. 中国发明专利, 专利号 CN 116455162 B, 授权公告日 2021-05-02.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Phytochemistry, 2022, 1877, (8), 4146-4167.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2024, 1356, 2550-2580.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 3,4-Difluoro-N-[(1S)-1-[6-[4-(2-pyridinyl)-1-piperazinyl]-2-pyrazinyl]ethyl]benzenepropanamide Using HRMS and NMR". Anal. Chim. Acta, 2020, 2227, (5), 1963-1978.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2010, 2372, (2), 6734-6746.